Top Page | English | 简体中文 | 繁體中文 | 한국어 | 日本語
  Press Releases
Wednesday, November 7, 2018
Singapore eDevelopment (SGX:40V) Subsidiary, Global BioLife, Proudly Announces Presentation of Parkinson's Research at Neuroscience 2018
Monday, June 18, 2018
Singapore eDevelopment Announces Corporate and Business Update
Thursday, May 31, 2018
Singapore Exchange-Listed Singapore eDevelopment Limited's U.S. Biomedical Subsidiary Global BioLife, Inc. Develops Low Glycemic Modified Sugar
Thursday, March 1, 2018
Singapore eDevelopment (SGX:40V) biomedical subsidiary confirms LB2 efficacy against Ebola
Wednesday, November 1, 2017
Singapore eDevelopment's Biomedical Subsidiary Confirms 100% Repellency of 3F Mosquito Fragrance
Tuesday, October 24, 2017
SGX-Listed Singapore eDevelopment's Global BioLife Inc Develops Breakthrough Modified Sugar
Tuesday, August 15, 2017
Singapore eDevelopment's Global BioLife and U.S.-based Chemia Corporation to Develop Functional Fragrances to Fight Mosquito-Borne Diseases
Thursday, June 15, 2017
First-Year Performance of Global Systematic Multi-Strategy Fund
Monday, May 22, 2017
Singapore eDevelopment Subsidiary Initiates Research on New Universal Drug Platform

Copyright © 2018 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 800 291 0906 | Beijing: +86 10 8405 3688 | Hong Kong: +852 2217 2912 | Singapore: +65 6304 8926 | Tokyo: +81 3 6721 7212

Connect With us: